RVPHW | Reviva Pharmaceuticals Holdings, Inc. Annual &

Annual Income Statements

(In USD)

Breakdown	2022	2021	2020	2020
Revenue	-	-	-	-
Cost of Revenue	-	-	724.74 Thousand	-
Gross Profit	-	-	-724.74 Thousand	-
Operating Expenses	24.3 Million	10.1 Million	2.43 Million	376.86 Thousand
Selling, General and Administrative Expenses	5.35 Million	5.25 Million	2.13 Million	181.11 Thousand
Research and Development Expenses	18.94 Million	4.85 Million	295.15 Thousand	195.74 Thousand
Other Expenses	-	-	-	-
Cost and Expenses	24.3 Million	10.1 Million	2.43 Million	376.86 Thousand
Operating Income	-24.3 Million	-10.1 Million	-2.43 Million	-376.86 Thousand
Interest Expense	182.8 Thousand	2414.00	1.45 Million	469.37 Thousand
Income Tax Expense	20.77 Thousand	6004.00	800.00	800.00
Earnings before Tax	-24.31 Million	-8.51 Million	-3.78 Million	-846.03 Thousand
Net Income	-24.33 Million	-8.52 Million	-3.78 Million	-846.83 Thousand
Earnings Per Share Basic	-1.25	-0.58	-1.24	-0.31
Earnings Per Share Diluted	-1.25	-0.58	-1.24	-0.31
Weighted Average Shares Outstanding	19.51 Million	14.79 Million	3.06 Million	2.77 Million
Weighted Average Shares Outstanding (Diluted)	19.51 Million	14.79 Million	3.06 Million	2.77 Million
Gross Margin	-	-	-	-
EBIT Margin	-	-	-	-
Profit Margin	-	-	-	-
EBITDA	-24.11 Million	-10.1 Million	-2.32 Million	-376.01 Thousand
Earnings Before Tax Margin	-	-	-	-

Breakdown	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 FY	2022 Q3
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	10.7 Million	12.07 Million	6.73 Million	7.77 Million	24.3 Million	3.56 Million
Selling, General and Administrative Expenses	1.99 Million	3.07 Million	1.5 Million	1.47 Million	-	1.25 Million
Research and Development Expenses	8.71 Million	8.99 Million	5.23 Million	6.29 Million	-	2.3 Million
Other Expenses	5194.00	-19.00	-14.49 Thousand	-	-	-
Cost and Expenses	10.7 Million	12.07 Million	6.73 Million	7.77 Million	24.3 Million	3.56 Million
Operating Income	-10.7 Million	-12.07 Million	-6.73 Million	-7.77 Million	-24.3 Million	-3.56 Million
Interest Expense	5901.00	12.75 Thousand	7655.00	133.29 Thousand	182.8 Thousand	49.5 Thousand
Income Tax Expense	12.11 Thousand	6436.00	2978.00	8363.00	20.77 Thousand	1864.00
Earnings before Tax	-10.47 Million	-12.43 Million	-6.59 Million	-8.1 Million	-24.31 Million	-3.51 Million
Net Income	-10.49 Million	-12.44 Million	-6.6 Million	-8.11 Million	-24.33 Million	-3.51 Million
Earnings Per Share Basic	-0.44	-0.55	-0.30	-0.42	-	-0.18
Earnings Per Share Diluted	-0.44	-0.55	-0.30	-0.42	-	-0.18
Weighted Average Shares Outstanding	24.03 Million	22.43 Million	21.83 Million	19.51 Million	19.51 Million	19.26 Million
Weighted Average Shares Outstanding (Diluted)	24.03 Million	22.43 Million	21.83 Million	19.51 Million	19.51 Million	19.26 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-10.61 Million	-11.96 Million	-6.6 Million	-7.31 Million	-	-3.56 Million
Earnings Before Tax Margin	-	-	-	-	-	-